Fredericksburg boy returning home after inclusion in drug trial - NBC12 - WWBT - Richmond, VA News On Your Side

Fredericksburg boy returning home after inclusion in drug trial


A Fredericksburg boy fighting a deadly virus is headed home after successfully lobbying a pharmaceutical company to be included in a drug trial.

Josh Hardy's family was able to convince Chimerix to allow their 7-year-old to receive brincidofovir. They hoped the drug would help him recover from adenovirus, which he came down with after a bone marrow transplant.

Their efforts paid off and Chimerix received approval from the Food and Drug Administration in March to release the drug to Josh as part of a pilot trial of open-label brincidofovir for the treatment of adenovirus infections in immunocompromised patients.

He then spent the past six-and-a-half months at St. Jude's Medical Center in Memphis receiving treatments and his family announced Tuesday night Josh is healthy enough to go home.

"His kidney function has returned and he is free of the need of dialysis. His heart function is within normal range. His lung function is perfect. His tummy is coming around," his mother, Aimee, wrote on his Facebook page. "He has not had the need of a blood transfusion in a month and with a lot of hard work his strength will return. He can walk a nice distance holding my hands and we anticipate the return of his immunity in a few months."

The family calls Josh's recovery an answer to their prayers. He will still have to go back to Memphis later this month, as well as return for monthly appointments until January.

Copyright 2014 WWBT NBC12. All rights reserved.
Powered by Frankly